These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 10447031)
41. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950 [TBL] [Abstract][Full Text] [Related]
42. The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP. Robbins JB; Schneerson R; Keith JM; Shiloach J; Miller M; Trollors B Vaccine; 2007 Apr; 25(15):2811-6. PubMed ID: 17291636 [TBL] [Abstract][Full Text] [Related]
43. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781 [TBL] [Abstract][Full Text] [Related]
44. WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom. Xing DK; Corbel MJ; Dobbelaer R; Knezevic I Vaccine; 2007 Apr; 25(15):2749-57. PubMed ID: 17368348 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Purdy KW; Hay JW; Botteman MF; Ward JI Clin Infect Dis; 2004 Jul; 39(1):20-8. PubMed ID: 15206048 [TBL] [Abstract][Full Text] [Related]
46. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine. Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366 [TBL] [Abstract][Full Text] [Related]
47. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study. Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794 [TBL] [Abstract][Full Text] [Related]
48. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395 [TBL] [Abstract][Full Text] [Related]
49. An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine. Pichichero ME; DeTora LM; Johnson DR Expert Rev Vaccines; 2006 Apr; 5(2):175-87. PubMed ID: 16608418 [TBL] [Abstract][Full Text] [Related]
50. [Pertussis vaccine in adolescents and adults]. Lévy J; Swennen B; Van Laethem Y Rev Med Brux; 2004 Sep; 25(4):A229-32. PubMed ID: 15516047 [TBL] [Abstract][Full Text] [Related]
56. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. de Greeff SC; Mooi FR; Schellekens JF; de Melker HE Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916 [TBL] [Abstract][Full Text] [Related]
57. The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins. Robbins JB; Schneerson R; Trollfors B; Sato H; Sato Y; Rappuoli R; Keith JM J Infect Dis; 2005 Jan; 191(1):81-8. PubMed ID: 15593007 [TBL] [Abstract][Full Text] [Related]
58. [Lifelong protection against pertussis]. Riffelmann M; Wirsing von König CH Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S86-9. PubMed ID: 19353478 [TBL] [Abstract][Full Text] [Related]
59. Public health perspectives on the rising incidence of pertussis. Judelsohn RG; Koslap-Petraco MB Public Health Nurs; 2007; 24(5):421-8. PubMed ID: 17714226 [TBL] [Abstract][Full Text] [Related]